Dr. Daniel H. Rich, Emeritus Ralph F. Hirschmann Professor of Medicinal And Organic Chemistry at the University of Wisconsin-Madison has been named as the 2017 recipient of the Meienhofer Award for Excellence in Peptide Sciences.The award will be presented to Dr. Rich on September 27, 2017 at the Boulder Peptide Symposium, which will take place from September 25 to 28, 2017 in Boulder, Colorado, where Dr. Rich will give a presentation of highlights from his prodigious record of research achievements. Read the announcement
The Meienhofer Award was established in 2007 to annually recognize an individual with a lifetime of achievement in peptide science. The award is named after Johannes Meienhofer, in honor of his transformative discoveries in solid phase peptide synthesis. Notably Meienhofer's work demonstrated the power of medicinal chemistry in peptide pharmacology and is considered to have laid the foundation of modern synthetic peptide therapeutics.
The Meienhofer Award therefore seeks to recognize individuals who have continued in Meienhofer's tradition of innovation in synthetic peptide therapeutics.
One of the two lasting contributions was the innovation of a “milder” chemistry for SPPS. Meienhofer applied Carpino’s Fmoc group to stepwise SPPS, in conjugation with mildly acid labile side-chain and anchorage chemistries to give rise to Fmoc/tBu SPPS. The impact of this work on the synthesis of peptide pharmaceuticals cannot be overstated. Dr. Meienhofer other seminal contribution was his scholarly work in the editing of the nine volume series, The Peptides: Analysis, Synthesis and Biology, which appeared between 1979 and 1987. Dr. Meienhofer was very active in the American Peptide Symposium. He organized the Third APS in Boston in 1972, which was the first Peptide Symposium open to everyone worldwide. This highly successful symposium became a model for subsequent symposia, both in America and Europe.
University of Arizona, USA
Institut des Biomolécules Max Mousseron, Université de Montpellier, France
Department of Biochemistry and Cancer Biology
Ombudsman, The University of Toledo College of Medicine and Life Sciences, USA
Hoffmann La-Roche, Nutley, New Jersey, USA
Veterans Affairs Medical Center, Miami, USA
Massachusetts Institute of Technology, USA